1.
Respirol Case Rep
; 9(12): e0858, 2021 Dec.
Article
in English
| MEDLINE
| ID: mdl-34786202
ABSTRACT
Convalescent plasma (CP) transfusion has been utilized as a salvage therapy in immunocompromised patients with severe COVID-19 pneumonia. We describe the case of a 45-year-old immunocompromised patient, who received CP, in order to control multiple COVID-19 flares and prolonged SARS-CoV-2 viraemia lasting for 2 months after the initial diagnosis.